Retrospective, Non-interventional, Comparative Clinical Investigation of the Safety and Performance of 690AD and 690ADY Monofocal Intraocular Lens Implantation With Extended Patient Enrolment

Inclusion Criteria: * Adult males or females above 18 years of age; * Pseudophakic patients implanted with 690AD or 690ADY monofocal IOLs (implanted between June 2022 - September 2023); * Diagnosis of cataract and/or ametropia (hyperopia, myopia); * Subject who has signed an informed consent form. * Patients who have participated in all visits that are subject to retrospective data collection. Exclusion Criteria: * Patients who are not targeted to emmetropia. * Patients with the following condition(s) at the time of the baseline visit: * Corneal astigmatism \> 1.0D * Uncontrolled diabetic retinopathy * Iris neovascularization * Congenital eye abnormality * Uncontrolled glaucoma * Pseudoexfoliation syndrome * Amblyopia * Uveitis * AMD (advanced AMD) * Retinal detachment * Prior ocular surgery in personal medical history * Previous laser treatment * Corneal diseases * Severe retinal diseases (dystrophy, degeneration) * High myopia * Inadequate visualization of the fundus on preoperative examination * Patients deemed by the clinical investigator because of any systemic disease * Pregnancy * Eye trauma in medical history * Current use of systemic steroids or topical ocular medication * Patients with any eye condition that could affect vision in the opinion of the investigator at the time of the 12-month follow-up: (corneal ectasia, retinal diseases, glaucoma, uveitis, dry eye or amblyopia, etc.);